Suppr超能文献

甲状腺功能亢进患者的尿N-乙酰-β-D-氨基葡萄糖苷酶

Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.

作者信息

Tominaga M, Fujiyama K, Hoshino T, Tanaka Y, Takeuchi T, Honda M, Mokuda O, Ikeda T, Mashiba H

机构信息

First Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.

出版信息

Horm Metab Res. 1989 Aug;21(8):438-40. doi: 10.1055/s-2007-1009256.

Abstract

Urinary N-acetyl-beta-D-glucosaminidase (NAG) was measured in patients with hyperthyroidism. The value of urinary NAG in these patients was higher than that in normal subjects and diabetic patients without diabetic nephropathy. This high level of urinary NAG in patients with hyperthyroidism decreased to the level of normal subjects after treatment of hyperthyroidism. Why urinary NAG increases in the patients with hyperthyroidism remains unknown. On the occasion of estimating the significance of the high level of urinary NAG, however, the possibility of the existence of hyperthyroidism has to be considered in addition to renal damage or hyperglycemia which have already been found to increase urinary NAG.

摘要

对甲状腺功能亢进患者测定了尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)。这些患者的尿NAG值高于正常人和无糖尿病肾病的糖尿病患者。甲状腺功能亢进患者的这种高水平尿NAG在甲状腺功能亢进治疗后降至正常受试者水平。甲状腺功能亢进患者尿NAG升高的原因尚不清楚。然而,在评估高水平尿NAG的意义时,除了已经发现会增加尿NAG的肾损害或高血糖外,还必须考虑存在甲状腺功能亢进的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验